Syra Health Corp. (NASDAQ:SYRA – Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 208,200 shares, a growth of 63.2% from the September 30th total of 127,600 shares. Based on an average daily trading volume, of 255,700 shares, the days-to-cover ratio is presently 0.8 days. Approximately 2.8% of the shares of the company are short sold.
Syra Health Price Performance
Syra Health stock opened at $0.40 on Friday. The business’s 50-day moving average price is $0.64 and its 200 day moving average price is $1.10. The firm has a market cap of $2.59 million and a price-to-earnings ratio of -0.60. Syra Health has a 52 week low of $0.34 and a 52 week high of $8.37.
Syra Health (NASDAQ:SYRA – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.21) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.02). Syra Health had a negative return on equity of 201.13% and a negative net margin of 59.22%. The firm had revenue of $1.97 million for the quarter, compared to analyst estimates of $1.79 million. Equities analysts expect that Syra Health will post -0.86 EPS for the current year.
About Syra Health
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.
Further Reading
- Five stocks we like better than Syra Health
- How is Compound Interest Calculated?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Trading Halts Explained
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- EV Stocks and How to Profit from Them
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.